![]() |
|
Karen Koopman1; Maarten Uyttenboogaart1; Patrick C. A. J. Vroomen1; Jan van der Meer2*; Jacques De Keyser1,3;
Gert-Jan Luijckx1
1Department of Neurology, University Medical Centre Groningen, University of Groningen, The Netherlands; 2Department of Haematology,
University Medical Centre Groningen, University of Groningen, The Netherlands; 3Department of Neurology, Universitair Ziekenhuis Brussel,
Vrije Universiteit, Brussel, Belgium
Cerebral venous thrombosis (CVT) and deep vein thrombosis or pulmonary embolism (DVT/PE) are associated with many risk factors. It is unclear why CVT occurs less often than DVT/PE. Age dependent risk factors may play a role. The aim of our study was to compare risk factors in a uniform age group of CVT and DVT/PE patients aged between 15 and 50 years. Thrombophilic markers and clinical risk factors of 79 CVT patients and 173 DVT/PE patients aged 15–50 years were compared. Multivariable logistic regression analysis was performed to investigate if risk factors were independently associated with CVT or DVT/ PE. Cerebral venous thrombosis patients were younger (median age 30 years vs. 42 years; p<0.001) and more often female (82% vs. 52%; p<0.001). There were no differences in thrombophilic markers. Cerebral venous thrombosis was less often associated with trauma, immobilisation or surgery than DVT/PE (6% vs. 21%; adjusted OR 0.29; 95%CI 0.10–0.82). In women, CVT was more frequently associated with oral contraceptive use, pregnancy or puerperium (82% vs. 53%; adjusted OR 2.34; 95%CI 1.03–5.32). This study demonstrated no differences in thrombophilic markers between CVT patients and DVT/PE patients aged between 15 and 50 years, while the frequency of some transient risk factors was different. Cerebral venous thrombosis was relatively more common in women and hormonal factors may predispose to CVT compared to DVT/PE, while trauma, immobilisation and surgery may be less important in the pathophysiology of CVT.
Risk Factors, Deep venous thrombosis, thrombosis, Venous thrombosis, cerebral venous thrombosis
| 1. | ||
Nadine S. Gibson1, Maaike Sohne1, Marieke J. H. A. Kruip2, Lidwine W. Tick3, Victor E. Gerdes1, Patrick M. Bossuyt4, Philip S. Wells5, Harry R. Buller1 on behalf of the Christopher study investigators Thrombosis and Haemostasis 2008 99 1: 229-234 http://dx.doi.org/10.1160/TH07-05-0321 | ||
| 2. | ||
Elisabeth R. Pomp1, Frits R. Rosendaal1–3, Carine J. M. Doggen1 Thrombosis and Haemostasis 2008 99 1: 59-63 http://dx.doi.org/10.1160/TH07-07-0470 | ||
| 3. | ||
Willem M. Lijfering1, Michiel Coppens2, Marlène H. W. van de Poel1, Saskia Middeldorp2, Karly Hamulyák3, Ivan Bank2, Nic J. G. M. Veeger1, Martin H. Prins4, Harry R. Büller2, Jan van der Meer1 Thrombosis and Haemostasis 2007 98 2: 457-563 http://dx.doi.org/10.1160/TH07-02-0138 | ||